Applied BioCode Corporation (6598.TW)

TWD 20.35

(-0.97%)

Total Assets Summary of Applied BioCode Corporation

Applied BioCode Corporation's latest annual total assets in 2023 was 993.2 Million TWD , down -18.08% from previous year.
Applied BioCode Corporation's latest quarterly total assets in 2024 Q2 was 926 Million TWD , down -3.76% from previous quarter.
Applied BioCode Corporation reported annual total assets of 1.21 Billion TWD in 2022, up 18.99% from previous year.
Applied BioCode Corporation reported annual total assets of 1.01 Billion TWD in 2021, down -16.97% from previous year.
Applied BioCode Corporation reported quarterly total assets of 962.2 Million TWD for 2024 Q1, down -3.12% from previous quarter.
Applied BioCode Corporation reported quarterly total assets of 993.2 Million TWD for 2023 Q4, down -12.54% from previous quarter.

Annual Total Assets Chart of Applied BioCode Corporation (2023 - 2012)

Historical Annual Total Assets of Applied BioCode Corporation (2023 - 2012)

Year	Total Assets	Total Assets Growth
2023	993.2 Million TWD	-18.08%
2022	1.21 Billion TWD	18.99%
2021	1.01 Billion TWD	-16.97%
2020	1.22 Billion TWD	70.68%
2019	719 Million TWD	39.87%
2018	514.07 Million TWD	52.62%
2017	336.82 Million TWD	-29.65%
2016	478.76 Million TWD	53.95%
2015	310.99 Million TWD	-12.31%
2014	354.66 Million TWD	82.29%
2013	194.55 Million TWD	-26.02%
2012	262.99 Million TWD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	926 Million TWD	-3.76%
2024 Q1	962.2 Million TWD	-3.12%
2023 Q4	993.2 Million TWD	-12.54%
2023 FY	993.2 Million TWD	-18.08%
2023 Q2	1.12 Billion TWD	-1.52%
2023 Q3	1.13 Billion TWD	0.62%
2023 Q1	1.14 Billion TWD	-5.48%
2022 Q1	983.14 Million TWD	-3.52%
2022 Q2	1.26 Billion TWD	29.01%
2022 Q4	1.21 Billion TWD	-6.78%
2022 Q3	1.3 Billion TWD	2.55%
2022 FY	1.21 Billion TWD	18.99%
2021 FY	1.01 Billion TWD	-16.97%
2021 Q3	1.06 Billion TWD	-5.03%
2021 Q4	1.01 Billion TWD	-3.9%
2021 Q1	1.2 Billion TWD	-2.13%
2021 Q2	1.11 Billion TWD	-7.04%
2020 Q1	671.26 Million TWD	-6.64%
2020 Q2	1.26 Billion TWD	89.0%
2020 Q3	1.24 Billion TWD	-2.1%
2020 Q4	1.22 Billion TWD	-1.2%
2020 FY	1.22 Billion TWD	70.68%
2019 Q1	- TWD	-100.0%
2019 FY	719 Million TWD	39.87%
2019 Q3	906.7 Million TWD	62.67%
2019 Q2	557.39 Million TWD	0.0%
2019 Q4	719 Million TWD	-20.7%
2018 Q2	243.34 Million TWD	0.0%
2018 FY	514.07 Million TWD	52.62%
2018 Q4	514.07 Million TWD	0.0%
2018 Q1	243.34 Million TWD	-27.75%
2017 FY	336.82 Million TWD	-29.65%
2017 Q2	325.95 Million TWD	0.0%
2017 Q1	325.95 Million TWD	-31.92%
2017 Q3	336.82 Million TWD	3.34%
2017 Q4	336.82 Million TWD	0.0%
2016 Q2	413.99 Million TWD	0.0%
2016 Q4	478.76 Million TWD	0.0%
2016 FY	478.76 Million TWD	53.95%
2015 FY	310.99 Million TWD	-12.31%
2015 Q4	310.99 Million TWD	0.0%
2014 FY	354.66 Million TWD	82.29%
2013 FY	194.55 Million TWD	-26.02%
2012 FY	262.99 Million TWD	0.0%

Peer Total Assets Comparison of Applied BioCode Corporation

Name	Total Assets	Total Assets Difference
Excelsior Medical Co., Ltd.	18.07 Billion TWD	94.507%
Apex Medical Corp.	3.22 Billion TWD	69.201%
OK Biotech Co., Ltd.	3.06 Billion TWD	67.62%